Created at Source Raw Value Validated value
June 25, 2024, noon usa

* have contraindications to vaccine and any significant reactions to vaccines * have any primary or secondary immune deficiencies or autoimmune disease/immunocompromised * have symptoms of covid-19 at the time of enrollment (eg. fever, headaches, muscle pain, sore throat, coughing, loss of smell, loss of taste, etc.) * have already received a covid-19 vaccine * are using any immune altering medications such as corticosteroids, cyclospoin, tacrolimus, and pimecrolimus * are unable to receive omt with lymphatic techniques due to open wounds, fractures, anuresis, necrotizing faciitis, congestive heart failure, or unstable cardiac conditions * are pregnant or breastfeeding * are less than 18 years of age or more than 65 years of age * were previously treated for covid-19 with serum transfer or immunological treatments * are on anti-coagulation therapy

* have contraindications to vaccine and any significant reactions to vaccines * have any primary or secondary immune deficiencies or autoimmune disease/immunocompromised * have symptoms of covid-19 at the time of enrollment (eg. fever, headaches, muscle pain, sore throat, coughing, loss of smell, loss of taste, etc.) * have already received a covid-19 vaccine * are using any immune altering medications such as corticosteroids, cyclospoin, tacrolimus, and pimecrolimus * are unable to receive omt with lymphatic techniques due to open wounds, fractures, anuresis, necrotizing faciitis, congestive heart failure, or unstable cardiac conditions * are pregnant or breastfeeding * are less than 18 years of age or more than 65 years of age * were previously treated for covid-19 with serum transfer or immunological treatments * are on anti-coagulation therapy

June 18, 2021, 12:32 a.m. usa

- have contraindications to vaccine and any significant reactions to vaccines - have any primary or secondary immune deficiencies or autoimmune disease/immunocompromised - have symptoms of covid-19 at the time of enrollment (eg. fever, headaches, muscle pain, sore throat, coughing, loss of smell, loss of taste, etc.) - have already received a covid-19 vaccine - are using any immune altering medications such as corticosteroids, cyclospoin, tacrolimus, and pimecrolimus - are unable to receive omt with lymphatic techniques due to open wounds, fractures, anuresis, necrotizing faciitis, congestive heart failure, or unstable cardiac conditions - are pregnant or breastfeeding - are less than 18 years of age or more than 65 years of age - were previously treated for covid-19 with serum transfer or immunological treatments - are on anti-coagulation therapy

- have contraindications to vaccine and any significant reactions to vaccines - have any primary or secondary immune deficiencies or autoimmune disease/immunocompromised - have symptoms of covid-19 at the time of enrollment (eg. fever, headaches, muscle pain, sore throat, coughing, loss of smell, loss of taste, etc.) - have already received a covid-19 vaccine - are using any immune altering medications such as corticosteroids, cyclospoin, tacrolimus, and pimecrolimus - are unable to receive omt with lymphatic techniques due to open wounds, fractures, anuresis, necrotizing faciitis, congestive heart failure, or unstable cardiac conditions - are pregnant or breastfeeding - are less than 18 years of age or more than 65 years of age - were previously treated for covid-19 with serum transfer or immunological treatments - are on anti-coagulation therapy